SPRED3 Activators
SPRED3 activators are a collection of compounds that indirectly enhance the functional activity of SPRED3 by influencing various signaling pathways in which this protein is a critical modulator. For instance, Forskolin raises intracellular cAMP levels, which activates PKA, leading to the phosphorylation of proteins that are part of the Ras/ERK/MAPK pathway, thus enhancing the negative feedback regulation role of SPRED3. Sildenafil, by inhibiting PDE5, and Rolipram, by inhibiting PDE4, both prevent the degradation of cyclic nucleotides, potentiating the PKA and PKG pathways and thereby potentially enhancing SPRED3 activity. Okadaic Acid, through the inhibition of phosphatases, leads to an increase in phosphorylated proteins, indirectly enhancing the MAPK pathway activity and the function of SPRED3. EGCG, as an antioxidant, may modulate the MAPK pathway and thus influence the activity of SPRED3, while Bisindolylmaleimide I, a PKC inhibitor, might shift signaling pathways to favor those regulated by SPRED3.
Anisomycin, as a JNK activator, and ZM-447439, as an Aurora kinase inhibitor, may indirectly enhance SPRED3's regulatory functions in their respective pathways. Caffeine, by inhibiting phosphodiesterases, results in elevated cAMP levels and subsequent PKA activation, potentially facilitating SPRED3's modulatory role in cAMP-dependent signaling pathways. These chemical activators, through their targeted effects on cellular signaling, serve to enhance the regulatory functions of SPRED3 without directly increasing its expression or activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate and activate proteins involved in the Ras/ERK/MAPK pathway, leading to an enhancement of SPRED3's function in negative feedback regulation of this pathway. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits PDE4, leading to increased cAMP levels, which in turn activates PKA. PKA can phosphorylate components of the Ras/ERK/MAPK pathway, indirectly enhancing the role of SPRED3 in this signaling cascade by modulating the pathway's intensity and duration. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins. This results in the indirect activation of the MAPK pathway, potentially enhancing the activity of SPRED3 by modulating the phosphorylation state of proteins that SPRED3 interacts with. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a potent antioxidant that has been shown to modulate various signaling pathways, including the MAPK pathway. By altering this pathway, EGCG could indirectly enhance the function of SPRED3 by affecting the pathway's dynamics and SPRED3's role within it. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific inhibitor of PKC, which is involved in multiple signaling pathways. Inhibition of PKC can lead to a re-balance in cell signaling that favorably affects pathways where SPRED3 acts as a regulator. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that could indirectly enhance SPRED3 activity by modulating the JNK pathway, which intersects with pathways regulated by SPRED3, potentially affecting its functional activity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine acts as a competitive inhibitor of phosphodiesterases, leading to increased cAMP levels. This can activate PKA and thus indirectly enhance SPRED3 activity by affecting cAMP-dependent signaling pathways where SPRED3 is involved. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor that disrupts mitotic progression. By influencing this pathway, it could potentially augment SPRED3's regulatory role in cell cycle-related signaling pathways. | ||||||